Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2019-07-04
Target enrollment:
Participant gender:
Summary
This is an open-label, combined 2-part multicenter study to evaluate the efficacy, safety,
and tolerability of blinatumomab in adult and pediatric Japanese patients with
relapsed/refractory B-precursor ALL.